Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.75 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.75 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.75 |
| ▸ | RAB9A | P51151 | 2/20 | 0.66 |
| ▸ | AGBL2 | Q5U5Z8 | 1/20 | 0.58 |
| ▸ | NPC1 | O15118 | 1/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.53 |
| ▸ | CMA1 | P23946 | 1/20 | 0.53 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.53 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.52 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL138875 | 1.00 | CYP3A4 (0.75) | CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A | |
| SCHEMBL3944098 | 1.00 | CYP3A4 (0.75) | CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A | |
| Hydrochloric Acid SCHEMBL8838333 | 0.98 | CYP3A4 (0.73) | CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A | |
| SCHEMBL7332204 | 0.98 | CYP3A4 (0.73) | CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A | |
| SCHEMBL2957608 | 0.92 | CYP3A4 (0.65) | CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A | |
| Piperonylic Acid SCHEMBL3936749 | 0.91 | ALDH1A1 (0.73) | CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A | |
| SCHEMBL286952 | 0.89 | ALDH1A1 (0.60) | CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A | |
| SCHEMBL7148530 | 0.87 | CYP3A4 (0.72) | CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A | |
| SCHEMBL13802498 | 0.86 | RAB9A (0.63) | CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A | |
| SCHEMBL31114377 | 0.86 | CYP3A4 (1.00) | CYP3A4ALDH1A1CYP1A2CYP2C19RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112061593-B | Multilayer protection inflatable packaging bag with self-adhesive film | 潮州市潮安区国强印务有限公司 | 2024-07-23 | — | — | CN | claimed |
| CN-116120271-A | Genipin derivative and preparation method and application thereof | 广东工业大学 | 2023-05-16 | — | — | CN | claimed |
| EP-4734977-A2 | NOVEL TRPV1 AGONISTS AND USES THEREOF | Neucures, Inc. (US) | 2026-05-06 | — | — | EP | disclosed |
| US-20260035381-A1 | COMPOUNDS AND COMPOSITIONS AND USES THEREOF | SUMITOMO PHARMA AMERICA, INC. (US) | 2026-02-05 | — | — | US | disclosed |
| US-20250295652-A1 | Inhibitors of Molluscum Contagiosum Infection and Methods Using the Same | UNIV PENNSYLVANIA (US) | 2025-09-25 | — | — | US | disclosed |
| WO-2025006675-A9 | NOVEL TRPV1 AGONISTS AND USES THEREOF | NEUCURES, INC. (US) | 2025-03-13 | — | — | WO | disclosed |
| WO-2025006675-A2 | NOVEL TRPV1 AGONISTS AND USES THEREOF | NEUCURES, INC. (US) | 2025-01-02 | — | — | WO | disclosed |
| WO-2024241318-A1 | ACTIVE MACROLIDE ANTIBIOTIC COMPOUNDS AGAINST PATHOGENS | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2024-11-28 | — | — | WO | disclosed |
| EP-4448515-A1 | PLPRO INHIBITORS | Shanghai Synergy Pharmaceutical Sciences Co., Ltd (CN) | 2024-10-23 | — | — | EP | disclosed |
| CN-118541359-A | Inhibitors of molluscum contagiosum infection and methods of use thereof | 宾夕法尼亚大学董事会 | 2024-08-23 | — | — | CN | disclosed |
| EP-4408833-A1 | INHIBITORS OF MOLLUSCUM CONTAGIOSUM INFECTION AND METHODS USING THE SAME | The Trustees of The University of Pennsylvania (US) | 2024-08-07 | — | — | EP | disclosed |
| CN-112061593-B | Multilayer protection inflatable packaging bag with self-adhesive film | 潮州市潮安区国强印务有限公司 | 2024-07-23 | — | — | CN | disclosed |
| WO-2023114379-A1 | PLPRO INHIBITORS | HUAHAI US INC. (US) | 2023-06-22 | — | — | WO | disclosed |
| CN-116120271-B | Genipin derivative and preparation method and application thereof | 广东工业大学 | 2023-06-20 | — | — | CN | disclosed |
| CN-116120271-A | Genipin derivative and preparation method and application thereof | 广东工业大学 | 2023-05-16 | — | — | CN | disclosed |
| WO-2023049919-A1 | INHIBITORS OF MOLLUSCUM CONTAGIOSUM INFECTION AND METHODS USING THE SAME | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2023-03-30 | — | — | WO | disclosed |
| CN-110885318-B | Benzoxazole derivative and preparation method and application thereof | 苏州大学 | 2022-12-23 | — | — | CN | disclosed |
| CN-111205236-B | Naphthalene ring-isoxazole type compound and preparation method and application thereof | 贵州医科大学 | 2022-07-01 | — | — | CN | disclosed |
| CN-111233766-B | Naphthalene ring-pyrazole compound and preparation method and application thereof | 贵州医科大学 | 2022-07-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260035381-A1 | COMPOUNDS AND COMPOSITIONS AND USES THEREOF | ADH1C, HTR6, CNR1 | CYP3A4 1078/4885ALDH1A1 231/4885CYP1A2 220/4885 |
| US-20250295652-A1 | Inhibitors of Molluscum Contagiosum Infection and Methods Using the Same | ITCH, EIF2AK2, TBK1 | CYP3A4 4591/4885ALDH1A1 3761/4885CYP1A2 4398/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.